sb 239063 has been researched along with Heart Disease, Ischemic in 1 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adult male rats were subjected to 30 min ischemia and 4 (apoptosis assay) or 24 h (myocardial infarction determination) of reperfusion and treated with vehicle, SB 239063, insulin or insulin plus wortmannin." | 3.72 | Early anti-apoptosis treatment reduces myocardial infarct size after a prolonged reperfusion. ( Christopher, TA; Gao, E; Gao, F; Liu, HR; Lopez, BL; Ma, XL; Tao, L; Yan, W, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F | 1 |
| Tao, L | 1 |
| Yan, W | 1 |
| Gao, E | 1 |
| Liu, HR | 1 |
| Lopez, BL | 1 |
| Christopher, TA | 1 |
| Ma, XL | 1 |
1 other study available for sb 239063 and Heart Disease, Ischemic
| Article | Year |
|---|---|
Early anti-apoptosis treatment reduces myocardial infarct size after a prolonged reperfusion.
Topics: Androstadienes; Animals; Apoptosis; Disease Models, Animal; Imidazoles; Insulin; Male; Myocardial In | 2004 |